# Reports
## Outbreak updates
### Global
#### [WHO Disease Outbreak News](https://github.com/midas-network/2019-ncov/tree/master/cases/who/disease_outbreak_news) ([metadata](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/collection_metadata.csv))
* 14 January, 2020 - [World Health Organization (WHO). (2020). Novel Coronavirus – Thailand (ex-China). Geneva.](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/WHO%20_%20Novel%20Coronavirus%20%E2%80%93%20Thailand%20(ex-China)_20200114.pdf)
* 16 January, 2020 - [World Health Organization (WHO). (2020). Emergencies preparedness, response Novel Coronavirus – China. Geneva.](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/WHO%20_%20Novel%20Coronavirus%20%E2%80%93%20Japan%20(ex-China)_20200116.pdf)
* 17 January, 2020 - [World Health Organization (WHO). (2020). Emergencies preparedness, response Novel Coronavirus – China. Geneva.](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/WHO%20_%20Novel%20Coronavirus%20%E2%80%93%20Japan%20(ex-China)_20200117.pdf)

* 21 January, 2020 - [World Health Organization (WHO). (2020). Emergencies preparedness, response Novel Coronavirus – China. Geneva.](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/WHO%20_%20Novel%20Coronavirus%20%E2%80%93%20Republic%20of%20Korea%20(ex-China)_20200121.pdf)


## Modelling reports
### China
17 January, 2020 - [Imai, N., Dorigatti, I., Cori, A., Riley, S., & Ferguson, N. M. (2020). Report 1: Estimating the potential total number of novel Coronavirus (2019-nCoV) cases in Wuhan City, China. London.](https://github.com/midas-network/2019-ncov/blob/master/Documents/reports/model_reports/china/2019-nCoV-outbreak-report-17-01-2020.pdf) 


# Pre-prints & Peer-Reviewed Papers
## Estimating Epidemiological Parameters

## Spread and Possibility of Containment

## Scenario Projections & Forecasting

## Impact of Interventions
18 January 2020 - [Cheng VCC, Wong S-C, To KKW, Ho PL, Yuen K-Y. Preparedness and proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China. J Hosp Infect. 2020:S0195-6701(20)30034-7.](https://doi.org/10.1016/j.jhin.2020.01.010)

28 January 2020 - [Lodge EK, Schatz AM, Drake JM. Protective Population Behavior Change in Outbreaks of Emerging Infectious Disease. bioRxiv. 2020:2020.01.27.921536.](https://doi.org/10.1101/2020.01.27.921536)

28 January 2020 - [Shao P, Shan Y. Beware of asymptomatic transmission: Study on 2019-nCoV prevention and control measures based on extended SEIR model. bioRxiv. 2020:2020.01.28.923169.](https://doi.org/10.1101/2020.01.28.923169)

02 February 2020 - [Quilty B, Clifford S, Flasche S, Eggo RM. Effectiveness of airport screening at detecting travellers infected with 2019-nCoV. medRxiv. 2020:2020.01.31.20019265.](https://doi.org/10.1101/2020.01.31.20019265)

02 February 2020 - [Tian H, Li Y, Liu Y, et al. Early evaluation of the Wuhan City travel restrictions in response to the 2019 novel coronavirus outbreak. medRxiv. 2020:2020.01.30.20019844.](https://doi.org/10.1101/2020.01.30.20019844)

03 February 2020 - [Gostic K, Gomez ACR, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of traveller screening to prevent international spread of 2019 novel coronavirus (2019-nCoV). medRxiv. 2020:2020.01.28.20019224.](https://doi.org/10.1101/2020.01.28.20019224)

5 February 2020 - [Ai S, Zhu G, Tian F, et al. Population movement, city closure and spatial transmission of the 2019-nCoV infection in China. medRxiv. 2020:2020.02.04.20020339.](https://doi.org/10.1101/2020.02.04.20020339)

07 February 2020 - [Muniz-Rodriguez K, Chowell G, Cheung C-H, et al. Epidemic doubling time of the 2019 novel coronavirus outbreak by province in mainland China. medRxiv. 2020:2020.02.05.20020750.](https://doi.org/10.1101/2020.02.05.20020750)

## Virus Evolution

## Clinical and Community Trials

## Observational Studies
January 24, 2020 - [Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … Gu, X. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan , China. The Lancet, 6736(20), 1–10.](https://doi.org/10.1016/S0140-6736(20)30183-5)



## Microbiological and Immunological studies
22 January 2020 - [Dong N, Yang X, Ye L, et al. Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China. bioRxiv. 2020:2020.01.20.913368.](https://doi.org/10.1101/2020.01.20.913368)

22 January 2020 - [Letko M, Munster V. Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV. bioRxiv. 2020:2020.01.22.915660.](https://doi.org/10.1101/2020.01.22.915660)

23 January 2020 - Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020:10.1038/s41586-020-2012-2017. [metadata]
- [Nature](https://doi.org/10.1038/s41586-020-2012-7)
- [bioRxiv](https://doi.org/10.1101/2020.01.22.914952)

25 January 2020 - [Li G, Fan Y, Lai Y, et al. Coronavirus Infections and Immune Responses. J Med Virol. 2020:10.1002/jmv.25685.](https://doi.org/10.1002/jmv.25685)

26 January 2020 - [Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020:2020.01.26.919985.](https://doi.org/10.1101/2020.01.26.919985)

28 January 2020 - [Tian X, Li C, Huang A, et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. bioRxiv. 2020:2020.01.28.923011.](https://doi.org/10.1101/2020.01.28.923011)

28 January 2020 - [Xu Z, Peng C, Shi Y, et al. Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv. 2020:2020.01.27.921627.](https://doi.org/10.1101/2020.01.27.921627)

29 January 2020 - [Liu X, Wang X-J. Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines. bioRxiv. 2020:2020.01.29.924100.](https://doi.org/10.1101/2020.01.29.924100)

30 January 2020 - [Li Y, Zhang J, Wang N, et al. Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening. bioRxiv. 2020:2020.01.28.922922.](https://doi.org/10.1101/2020.01.28.922922)

30 January - [Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England). 2020:S0140-6736(20)30251-8.](https://doi.org/10.1016/S0140-6736(20)30251-8)

30 January 2020 - [Pillaiyar T, Meenakshisundaram S, Manickam M. Recent discovery and development of inhibitors targeting coronaviruses. Drug Discov Today. January 2020:S1359-6446(20)30041-6.](https://doi.org/10.1016/j.drudis.2020.01.015)

31 January 2020 - [Chu DKW, Pan Y, Cheng SMS, et al. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. January 2020:hvaa029.](https://doi.org/10.1093/clinchem/hvaa029)

31 January 2020 - [Hoffmann M, Kleine-Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020:2020.01.31.929042.](https://doi.org/10.1101/2020.01.31.929042)

31 January 2020 - [Jiang S, Du L, Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect. 2020;9(1):275-277.](https://doi.org/10.1080/22221751.2020.1723441)

31 January 2020 - [Ju J, Kumar S, Li X, Jockusch S, Russo JJ. Nucleotide Analogues as Inhibitors of Viral Polymerases. bioRxiv. 2020:2020.01.30.927574.](https://doi.org/10.1101/2020.01.30.927574)

31 January 2020 - [Rut W, Żmudziński M, Snipas SJ, Bekes M, Huang TT, Drag M. Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes. bioRxiv. 2020:2020.01.30.926881.](https://doi.org/10.1101/2020.01.30.926881)

31 January 2020 - [Zhang H, Kang Z, Gong H, et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. 2020:2020.01.30.927806.](https://doi.org/10.1101/2020.01.30.927806)

2 February 2020 - [Beal J, Mitchell T, Wyschogrod D, Manthey J, Clore A. Highly Distinguished Amino Acid Sequences of 2019-nCoV (Wuhan Coronavirus). bioRxiv. 2020:2020.01.31.929497.](https://doi.org/10.1101/2020.01.31.929497)

2 February 2020 - [Beck BR, Shin B, Choi Y, Park S, Kang K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model. bioRxiv. 2020:2020.01.31.929547.](https://doi.org/10.1101/2020.01.31.929547)

3 February 2020 - [Lei C, Fu W, Qian K, et al. Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig. bioRxiv. 2020:2020.02.01.929976.](https://doi.org/10.1101/2020.02.01.929976)

3 February 2020 [Lin S, Shen R, Guo X. Molecular Modeling Evaluation of the Binding Abilities of Ritonavir and Lopinavir to Wuhan Pneumonia Coronavirus Proteases. bioRxiv. 2020:2020.01.31.929695.](https://doi.org/10.1101/2020.01.31.929695)

4 February 2020 - [Ahmed SF, Quadeer AA, McKay MR. Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies. bioRxiv. 2020:2020.02.03.933226.](https://doi.org/10.1101/2020.02.03.933226)

4 February 2020 - [Chai X, Hu L, Zhang Y, et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. bioRxiv. 2020:2020.02.03.931766.](https://doi.org/10.1101/2020.02.03.931766)

4 February 2020 - [Huang Q, Herrmann A. Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). bioRxiv. 2020:2020.02.01.930537.](https://doi.org/10.1101/2020.02.01.930537)

4 February 2020 - [Kritas SK, Ronconi G, Caraffa A, Gallenga CE, Ross R, Conti P. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. J Biol Regul Homeost Agents. 2019;34(1):10.23812/20-Editorial-Kritas.](https://doi.org/10.23812/20-Editorial-Kritas)

4 February 2020 - [Nguyen DD, Gao K, Wang R, Wei G. Machine intelligence design of 2019-nCoV drugs. bioRxiv. 2020:2020.01.30.927889.](https://doi.org/10.1101/2020.01.30.927889)

4 February 2020 - [Ramaiah A, Arumugaswami V. Insights into Cross-species Evolution of Novel Human Coronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development. bioRxiv. 2020:2020.01.29.925867.](https://doi.org/10.1101/2020.01.29.925867)

4 February 2020 - [Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. February 2020.](https://doi.org/10.1038/s41422-020-0282-0)

5 February 2020 - [Baruah V, Bose S. Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol. 2020.](https://doi.org/10.1002/jmv.25698)

5 February 2020 - [He X, Zhang L, Ran Q, et al. Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of 2019-nCoV. medRxiv. 2020:2020.02.03.20020206.](https://doi.org/10.1101/2020.02.03.20020206)

5 February 2020 - [Li H, Wang YM, Xu JY, Cao B. _Potential antiviral therapeutics for 2019 Novel Coronavirus_. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0):E002.](https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0002)

5 February 2020 - [Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based Drug Repurposing for Human Coronavirus. medRxiv. 2020:2020.02.03.20020263.](https://doi.org/10.1101/2020.02.03.20020263)

7 February 2020 - [Dennis Lo YM, Chiu RWK. Racing towards the development of diagnostics for a novel coronavirus (2019-nCoV). Clin Chem. February 2020:hvaa038.](https://doi.org/10.1093/clinchem/hvaa038)

7 February 2020 - [Wang J, Zhao S, Liu M, et al. ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism. medRxiv. 2020:2020.02.05.20020545.](https://doi.org/10.1101/2020.02.05.20020545)

7 February 2020 - [Xiao S-Y, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary/Review]. J Med Virol. February 2020:10.1002/jmv.25702.](https://doi.org/10.1002/jmv.25702)

## Other studies


# Guidelines
## WHO
## China
## United States


